|
"hwu cm"的相關文件
顯示項目 61-85 / 125 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2021-12 |
Early-onset type 2 diabetes <60 years and risk of vascular complications
|
Yen, FS;Lo, YR;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2021-11-18 |
The risk of nephropathy, retinopathy, and leg amputation in patients with diabetes and hypertension: A nationwide, population-based retrospective cohort study
|
Yen, FS;Wei, JCC;Shih, YH;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-07-01 |
Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
|
Yen, FS;Huang, YH;Hou, MC;Hwu, CM;Lo, YR;Shin, SJ;Hsu, CC |
| 國家衛生研究院 |
2021-07 |
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
|
Yen, FS;Wei, CC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-06-12 |
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
|
Yen, FS;Lai, JN;Wei, JCC;Chiu, LT;Hsu, CC;Hou, MC;Hwu, CM |
| 國家衛生研究院 |
2021-04-29 |
Urate-lowering therapy and chronic kidney disease development in patients with gout
|
Yen, FS;Wei, JCC;Chang, CL;Yang, CC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-04-12 |
Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose
|
Chung, RH;Chiu, YF;Wang, WC;Hwu, CM;Hung, YJ;Lee, IT;Chuang, LM;Quertermous, T;Rotter, JI;Chen, YDI;Chang, IS;Hsiung, CA |
| 國家衛生研究院 |
2021-03-05 |
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study
|
Yen, FS;Hsu, CC;Su, YC;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2021-02-18 |
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
|
Yen, FS;Wei, JC;Lin, MC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-01-10 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: A nationwide population-based cohort study in Taiwan
|
Yen, FS;Wei, JCC;Yip, HT;Hwu, CM;Hou, MC;Hsu, CC |
| 中山醫學大學 |
2021 |
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
|
Yen, FS; Wei, JCC; Lin, MC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
|
Yen, FS; Wei, JCC; Yang, YC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose
|
Chung, RH; Chiu, YF; Wang, WC; Hwu, CM; Hung, YJ; Lee, IT; Chuang, LM; Quertermous, T; Rotter, JI; Chen, YDI; Chang, IS; Hsiung, CA |
| 中山醫學大學 |
2021 |
Distinct associations of self-monitoring of blood glucose with glycemic control and hypoglycemia between groups of recently diagnosed and long-term follow-up type 2 diabetes: The Taiwan Diabetes Registry
|
Wang, JS; Lo, SH; Yeh, YP; Hwu, CM; Huang, CN; Hsieh, CH; Sheu, WHH |
| 中山醫學大學 |
2021 |
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy A nationwide retrospective cohort study
|
Yen, FS; Hsu, CC; Su, YC; Wei, JCC; Hwu, CM |
| 中山醫學大學 |
2021 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan
|
Yen, FS; Wei, JCC; Yip, HT; Hwu, CM; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2021 |
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
|
Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hsu, CC; Hou, MC; Hwu, CM |
| 中山醫學大學 |
2021 |
Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
|
Yen, FS; Wei, JCC; Chang, CL; Yang, CC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2021 |
Urate-lowering therapy exerts protective effects against hypertension development in patients with gout
|
Lin, KH; Yen, FS; Li, HL; Wei, JCC; Hsu, CC; Yang, CC; Hwu, CM |
| 國家衛生研究院 |
2020-12-14 |
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
|
Yen, FS;Lai, JN;Wei, JC;Chiu, LT;Hwu, CM;Hou, MC;Hsu, CC |
| 國家衛生研究院 |
2020-10-30 |
Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and liver cirrhosis
|
Yen, FS;Wei, JC;Chiu, LT;Hsu, CC;Hou, MC;Hwu, CM |
| 國家衛生研究院 |
2020-09 |
The factors associated with insulin nonpersistence in persons with type 2 diabetes
|
Yen, FS;Wei, JCC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2020-06-24 |
Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
|
Yen, FS;Wei, JC;Yang, YC;Hsu, CC;Hwu, CM |
顯示項目 61-85 / 125 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
